SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-23-072836
Filing Date
2023-08-31
Accepted
2023-08-31 16:16:12
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff12023a2_neurosensethera.htm F-1/A 739028
2 CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS ff12023a2ex23-1_neurosense.htm EX-23.1 1681
3 FILING FEE TABLE ff12023a2ex-fee_neurosense.htm EX-FILING FEES 15457
4 GRAPHIC tneuro_logo.jpg GRAPHIC 130396
5 GRAPHIC timage_001.jpg GRAPHIC 265787
  Complete submission text file 0001213900-23-072836.txt   1303109
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-273375 | Film No.: 231229235
SIC: 2834 Pharmaceutical Preparations